John K. Erban, MD
Division of Hematology/Oncology, Tufts Medical Center Cancer Center & Tufts University School of Medicine, Boston, MA, USA
Dr. Erban serves as Associate Director of Clinical Sciences and Clinical Director for the Tufts Cancer Center and Professor of Medicine at Tufts University School of Medicine. In this role he directs efforts to organize clinical research for the Tufts Cancer Center. As Director of the Neely Center for Clinical Research (NCCCR), and Vice Chair, Protocol Review and Management Committee he is involved in protocol design, review, execution and monitoring. His current research interests include new therapeutic agents for breast cancer and their rational use in advanced and locally advanced disease, with particular interest in inflammatory breast cancer. Work to date has focused on phase II and III evaluation of novel therapeutics, the role of high dose chemotherapy for women with breast cancer, the clinical characterization of inflammatory breast cancer, and development of a patient-specific predictive instrument to help predict need for dose reductions during adjuvant chemotherapy for breast cancer.
Dr. Erban has served in the past as Director of the Breast Cancer Program and Chief, Division of Hematology/Oncology (1997-2006) at Tufts Medical Center, Clinical Director of the Gillette Breast Center at Massachusetts General Hospital/Harvard Cancer Center (2007-2011) and Associate Professor of Medicine, Harvard Medical School. Dr. Erban is a member of the ECOG Breast Committee and a past member of the NCCN guidelines panel for Breast Cancer. He is currently Associate Editor, Amer. J. Clin Oncology and a past member of the editorial boards of the Journal of Clinical Oncology and Oncology, Index and Reviews. He has served on the boards of the Massachusetts Society of Clinical Oncology (President 2000-2002), the Cam Neely Foundation and the Silent Spring Environmental Research Institute, which selected him for its 2015 Rachel Carson Advocacy Award. He is a graduate of Harvard College (AB Chemistry) and Tufts University School of Medicine and he completed his training at Hospital of the University of Pennsylvania (IM) and Tufts Medical Center (Hematology/Oncology Fellowship).
Terms of Appointment: August, 2016 - July, 2018; August, 2018 - July, 2020